Resorufin: a lead for a new protein kinase CK2 inhibitor.
about
Regulation of DNA-dependent protein kinase by protein kinase CK2 in human glioblastoma cellsProtein kinase CK2 and human malignant tumorsLow-density crystal packing of human protein kinase CK2 catalytic subunit in complex with resorufin or other ligands: a tool to study the unique hinge-region plasticity of the enzyme without packing biasPre-clinical characterization of CX-4945, a potent and selective small molecule inhibitor of CK2 for the treatment of cancer.Emergence of protein kinase CK2 as a key target in cancer therapyIdentification of a novel potent, selective and cell permeable inhibitor of protein kinase CK2 from the NIH/NCI Diversity Set Library.Emodin Bidirectionally Modulates Macrophage Polarization and Epigenetically Regulates Macrophage Memory.D11-Mediated Inhibition of Protein Kinase CK2 Impairs HIF-1α-Mediated Signaling in Human Glioblastoma Cells.Knowledge-guided gene prioritization reveals new insights into the mechanisms of chemoresistance.Casein kinases as potential therapeutic targets.Emodin Inhibits Breast Cancer Growth by Blocking the Tumor-Promoting Feedforward Loop between Cancer Cells and Macrophages.Exploring the prominent performance of CX-4945 derivatives as protein kinase CK2 inhibitors by a combined computational study.Pharmacokinetic characterization of CK2 inhibitor CX-4945.
P2860
Q24296152-69BDE517-E3A7-4792-899D-685A91211677Q27026335-61ABAEBC-34F1-45E0-8B6A-5B2DB2D4AB45Q27681892-53363143-45C1-461A-A54D-490177C4FFA2Q33960547-C06F2533-640B-4F20-8A4E-6EA09379DA57Q34046848-BD37EFE6-355D-473B-9F9E-B015DB0650DDQ35627487-953CC083-DD5E-4AAB-B8EC-598C08E24CB9Q36941046-B334FBBF-1000-460C-BBDF-B4B3A9B829DFQ37731308-59D9287F-C76C-4577-9EB5-2F78D609DCB0Q38628538-73324B97-57B6-4074-9471-5FF62CAC55DFQ38632634-23C9D578-4347-4DC9-89D8-A2BAEBA5C025Q38769901-CA555D8C-7F20-4E3A-BF9D-A42476DB989BQ39227396-1879C8C6-C86C-4FFF-A353-B581337F0EF2Q45778656-CAA3F36D-A4F3-41F7-A3D1-A58775310839
P2860
Resorufin: a lead for a new protein kinase CK2 inhibitor.
description
2009 nî lūn-bûn
@nan
2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Resorufin: a lead for a new protein kinase CK2 inhibitor.
@ast
Resorufin: a lead for a new protein kinase CK2 inhibitor.
@en
type
label
Resorufin: a lead for a new protein kinase CK2 inhibitor.
@ast
Resorufin: a lead for a new protein kinase CK2 inhibitor.
@en
prefLabel
Resorufin: a lead for a new protein kinase CK2 inhibitor.
@ast
Resorufin: a lead for a new protein kinase CK2 inhibitor.
@en
P1433
P1476
Resorufin: a lead for a new protein kinase CK2 inhibitor.
@en
P2093
Iben Skjøth Sandholt
Olaf-Georg Issinger
P304
P356
10.1097/CAD.0B013E328326472E
P577
2009-04-01T00:00:00Z